DAIC

JULY 24, 2024

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. FDA 510(k) clearance and European CE Mark approval for its innovative products. The company has obtained U.S.

Atrial Fibrillation 105

Atrial Fibrillation AFIB Ablation Technology 105

DAIC

FEBRUARY 27, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study. The acquisition of Laminar, Inc.

Atrial Fibrillation 105

Atrial Fibrillation Innovation AFIB Pharmacology 105

HeartRhythm

AUGUST 27, 2024

The same holds true for the adoption of artificial intelligence (AI) by clinical cardiac electrophysiology.

Electrophysiology 40

Electrophysiology Technology Innovation Arrhythmia 40

HeartRhythm

APRIL 30, 2024

Loss-of-function SCN5A channelopathies, such as Brugada syndrome (BrS), are cardiac disorders marked by diminished sodium current (INa), conduction slowing, and lethal arrhythmias.

Pharmacology 40

Pharmacology Defibrillator Innovation Arrhythmia 40

DAIC

JANUARY 3, 2024

The Zio monitor ECG System secured its CE mark based on compliance to EU MDR standards of performance, quality, safety, and efficacy, along with the body of clinical evidence supporting Zio in detecting potential cardiac arrhythmias. Diagnostic Utility of a Novel Leadless Arrhythmia Monitoring Device, American Journal of Cardiology , 2013.

Technology 98

Technology Certification Arrhythmia Electrocardiogram 98

HeartRhythm

MARCH 26, 2024

Dr Wilkoff was an innovator in the field of cardiac implantable electronic devices (CIEDs). Wilkoff, MD, one of the most impactful and pioneering members of the Heart Rhythm Society (HRS).

Heart Rhythm 45

Heart Rhythm Electrophysiology Innovation Technology 45

DAIC

DECEMBER 27, 2023

With the unveiling of the Genesis System, Baptist Health Lexington has become the first in Kentucky, and one of the first in the world, to provide the latest advancement in robotic technology to treat cardiac arrhythmias. “We In 2006, Lewis realized something was not right with his heart during one of his regular outdoor runs.

Technology 105

Technology Heart Disease Heart Rhythm Arrhythmia 105

DAIC

JUNE 25, 2024

This AI technology can detect 35 cardiac determinations (14 arrhythmias and 21 morphologies), including serious conditions like acute myocardial infarction ( MI ) and the most common types of cardiac ischemia, using a reduced leadset. KAI 12L employs multiple deep neural network algorithms, trained and validated on more than 1.75

Technology 116

Technology Heart Attack Heart attacks Innovation 116

Frontiers in Cardiovascular Medicine

JANUARY 15, 2024

Despite the benefits of CA, a significant proportion of patients suffer a recurrence; hence, there is scope to potentially improve outcomes through technical innovations such as ablation index (AI) guidance during AF ablation. of patients remaining free from atrial arrhythmia at 1 year and 72.3% Age >75 years ( p  = 0.02, HR: 2.7,

Ablation 64

Ablation Atrial Fibrillation BMI Arrhythmia 64

Heart 2023 Conference

JANUARY 17, 2024

This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions. Koonlawee Nademanee, Director of the Bumrungrad Heart Institute in Thailand, have spearheaded the establishment of a world-class heart institute.

Congenital Heart Disease 49

Congenital Heart Disease Coronary Artery Disease Heart Transplant Transplant 49

DAIC

MAY 18, 2024

Atrial fibrillation is the most common type of arrhythmia, and by 2050, up to 16 million Americans are projected to have AF 1. The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients and is the primary information resource on heart rhythm disorders.

Atrial Fibrillation 105

Atrial Fibrillation Heart Rhythm Ablation Quality of Life 105

DAIC

JUNE 11, 2024

Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Until recently, therapeutic options for people with tricuspid and mitral valve disorders have been limited to symptom relief or high-risk surgery.

Tricuspid 111

Tricuspid Bicuspid/Mitral Heart Valves Innovation 111

DAIC

JANUARY 18, 2024

We have long known that pulsed field ablation could open up an entirely new frontier in how we treat people battling the most complex cardiac arrhythmias. But like any innovation, early solutions have not been able to fully capitalize on those potential benefits," said Professor Prash Sanders, M.B.B.S.,

Heart Rhythm 105

Heart Rhythm Ablation AFIB Chest Pain 105

Frontiers in Cardiovascular Medicine

DECEMBER 18, 2023

Background Cryoballoon ablation (CBA) and laser balloon ablation (LBA) are two innovative ways for the treatment of atrial fibrillation (AF). This study aimed to evaluate the efficacy and safety of cryoballoon ablation and laser balloon ablation in patients with AF. LBA presented a lower acute PVI rate per patients (CBA 97.0%

Atrial Fibrillation 64

Atrial Fibrillation Ablation Innovation Arrhythmia 64

DAIC

FEBRUARY 1, 2024

Different types of cardiovascular disease include atherosclerosis, heart failure and arrhythmias. These innovations can make it easier and more convenient for patients to manage atherosclerosis,” according to FactMR’s November 2023 market report. based on 2020 data used to compile AHA’s 2023 Statistical Update.

Cardiovascular Disease 104

Cardiovascular Disease Stroke Strokes Atherosclerosis 104

Journal of Cardiovascular Electrophysiology

OCTOBER 3, 2024

Abstract Introduction Pulsed field ablation (PFA) has emerged as an innovative therapy for cardiac arrhythmias. Infusion and uptake of calcium chloride during pulsed field ablation leads to greater irreversible electroporation and larger myocardial ablation lesions.

Ablation 45

Ablation Innovation Arrhythmia Research 45

Circulation

NOVEMBER 11, 2024

Cardiac fibrosis is a pathological hallmark of almost all forms of heart disease, characterized by excessive deposition of extracellular matrix (ECM) proteins by activated fibroblasts, leading to cardiomyocyte hypertrophy, arrhythmias, and heart failure.

Cardiac Function 40

Cardiac Function Pharmacology Innovation Heart Failure 40

DAIC

FEBRUARY 7, 2024

CTA and the ACC recognize there is strong potential for cardiac monitoring (through Consumer Cardiovascular Technology Solutions) to help identify and screen patients with Atrial Fibrillation (AFib) and related arrhythmias to alert the right clinical groups for early support and reduction in mortality rates.

Technology 116

Technology Cardiovascular Disease Best Practices AFIB 116

DAIC

DECEMBER 20, 2023

associate professor of biomedical research and translational medicine and scientific operations director at MMRI , recently published an innovative manuscript titled, Biomimetic Nanomaterials for the Immunomodulation of the Cardiosplenic Axis Post-Myocardial Infarction. McCarthy, Ph.D. McCarthy, Ph.D., Rajendran JC Bose, Ph.D.,

Heart Attack 115

Heart Attack Heart attacks Myocardial Infarction Research 115

DAIC

JULY 15, 2024

Health systems leveraging Guidehealth can seamlessly integrate Story Health’s program to support at-risk patients with heart conditions like heart failure, hypertension, and arrhythmia, providing better care while also reducing the total cost of care, according to a written statement detailing the deal.

Technology 105

Technology Innovation Nursing Heart Failure 105

DAIC

JANUARY 24, 2024

The Smidt Heart Institute recently received CAROL Act funding to study the connection between ventricular arrhythmias—abnormal heartbeats that start in the heart’s two lower chambers—and an elevated risk of sudden cardiac death in patients with mitral valve disease. Patients come to us from all over the U.S. and overseas for our expertise.

Bicuspid/Mitral 105

Bicuspid/Mitral Research Heart Valves Cardiac Arrest 105

DAIC

MARCH 28, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTec h i , announced the submission of the VARIPULSE Platform for Premarket Approval Application (PMA) to the U.S. milla1cf Thu, 03/28/2024 - 07:28 March 28, 2024 — Biosense Webster, Inc., Food & Drug Administration ( FDA ).

Atrial Fibrillation 110

Atrial Fibrillation AFIB Ablation Pulmonary 110

DAIC

OCTOBER 30, 2024

Director of Cardiac Arrhythmia Services for the Mount Sinai Health System in New York City. We will continue to fulfill our commitment to innovation, including new indications, to advance cardiovascular care and improve patient outcomes." The potential of Affera is limitless.

Ablation 52

Ablation AFIB Atrial Fibrillation Atrial Flutter 52

DAIC

APRIL 9, 2024

It is also published in Heart Rhythm , the official journal of the HRS, Journal of Arrhythmia , the official journal of the APHRS, and Journal of Interventional Cardiac Electrophysiology , the official journal of the LAHRS. Antiarrhythmic drugs are advised for some patients to prevent arrhythmia recurrences early after the procedure.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Heart Rhythm Blood Clot 105

DAIC

DECEMBER 22, 2023

David Newton , Clinical Cardiac Electrophysiologist at Memorial Health University Physicians Heart Care and Dr. Andrea Natale , Executive Medical Director at T exas Cardiac Arrhythmia Institute, St. David’s Medical Center. Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib.

Atrial Fibrillation 59

Atrial Fibrillation AFIB Ablation Arrhythmia 59

DAIC

JUNE 11, 2024

Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Until recently, therapeutic options for people with tricuspid and mitral valve disorders have been limited to symptom relief or high-risk surgery.

Tricuspid 52

Tricuspid Bicuspid/Mitral Heart Valves Innovation 52

DAIC

JULY 16, 2024

AFib is the most common type of irregular heart rhythm or arrhythmia. Individuals with potential arrhythmia episodes or a history of irregular rhythms can now track AFib closely and seek early intervention. UltraSignal will help fuel more customization and innovation in health.

AFIB 103

AFIB Technology Heart Rhythm Arrhythmia 103

DAIC

MARCH 1, 2024

Other Cedars-Sinai investigators who worked on the Circulation: Arrhythmia and Electrophysiology study include Bryan Bednarski; Harpriya Chugh; Habiba Aziz; Hoang Nhat Pham, MD; Arayik Sargsyan, MD; Audrey Uy-Evanado, MD; Damini Dey, PhD; and Kyndaron Reinier, PhD.

Cardiac Arrest 111

Cardiac Arrest Electrocardiogram Electrophysiology Defibrillator 111

DAIC

JANUARY 19, 2024

Chugh’s leadership in arrhythmia research and care is extraordinary,” said Eduardo Marbán, MD, PhD , executive director of the Smidt Heart Institute. Chugh is widely regarded among our electrophysiology community as one of our most innovative, dedicated and talented researchers.

Cardiac Arrest 105

Cardiac Arrest Heart Rhythm Electrophysiology Sudden Cardiac Death 105

DAIC

DECEMBER 19, 2023

OSA is commonly seen in patients with arrhythmias like atrial fibrillation (AFib) and due to the variable unpredictable nature of sleep apnea symptoms, it is often untreated, leading to adverse outcomes. Peerbridge Health continues to innovate by compounding clinical utility in one simple device," said Andrea Natale, M.D.,

Heart Failure 52

Heart Failure Innovation Heart Disease Quality of Life 52

GEMMS

MAY 22, 2024

In this article, we will explore the top 10 trends shaping the future of cardiovascular medicine, highlighting the innovative technologies and approaches that are revolutionizing the field. Innovative algorithms analyze gene biomarkers to provide predictive insights and personalized patient therapy.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

MIBHS

SEPTEMBER 15, 2023

Among these innovations, minimally invasive cardiac surgery stands out as a game-changer, offering numerous benefits over traditional open-heart surgery. Due to the prevalence of cardiovascular disease, there are continuous advancements in cardiac surgery techniques. This reduced risk enhances the overall safety profile of these procedures.

Open-Heart Surgery 52

Open-Heart Surgery Coronary Artery Bypass Graft Cardiovascular Disease Innovation 52

Wellnest

JUNE 19, 2023

With the continued evolution of AI, it is now being introduced in cardiac healthcare, promising opportunities for innovation and advancements in cardiovascular medicine. Alternatively, it also helps enhance arrhythmia management with coronary artery disease. For instance: 1. It improves the prediction model for myocardial scar mass.

Technology 52

Technology Cardiac Arrest Innovation Coronary Artery Disease 52

Dr. S. Venkatesan MD

JUNE 16, 2024

Any deviation or trespassing results in arrhythmia. We must thank the technological innovators in the electro-anatomical mapping system, who are continuously upgrading and providing the best to us. This is what DC shocks do for temporary reversion to sinus rhythm ) How to localize the diastolic pathways ?

Ablation 52

Ablation Physiology Technology Electrophysiology 52

DAIC

FEBRUARY 2, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , revealed findings from a company-funded study of real-world data. AFib is the most common type of cardiac arrhythmia and affects more than 6 million people in the United States and nearly 38 million people worldwide.2,3

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

CineECG

MAY 22, 2023

As ECG Excellence we are proud our CineECG technology was part of this innovation festival. Over the past 3 days cardiologists from all over the world met in New Orleans to learn and discuss the developments in technology and patient care. Today we focus on the results of Ramkumar Venkateswaran and Edward Gerstenfeld, both working in UCSF.

Technology 52

Technology Atrial Fibrillation Anatomy Innovation 52

ADN Center of Excellence

SEPTEMBER 28, 2023

Their expertise covers a wide range of cardiovascular conditions, including coronary artery disease, heart failure, arrhythmias, and congenital heart defects. Innovative Medications : The development of novel medications has expanded treatment options for heart conditions, improving patients' quality of life.

COVID-19 52

COVID-19 Heart Disease Education Interventional Cardiology 52